Aignostics is an artificial intelligence company that delivers AI-powered tissue analyses, validated by pathologists. By combining proprietary access to multimodal clinical data, industry-leading technologies, and rigorous science, Aignostics develops best-in-class products and services for the next generation of precision medicine, supporting both biopharma R&D and clinical routine diagnostics. Established in 2020, Aignostics is a spin-off from Charité Berlin, one of the world's largest and most esteemed university hospitals. Aignostics is funded by leading investors such as Mayo Clinic and has operations in Berlin and New York.
| Website | http://www.aignostics.com |
| Revenue | $21 million |
| Employees | 113 (98 on RocketReach) |
| Founded | 2018 |
| Address | Alt-Moabit 73, Berlin, Berlin 10555, DE |
| Technologies |
JavaScript
,
HTML
,
PHP
+15 more
(view full list)
|
| Industry | Software Development, Artificial Intelligence, Decision/Risk Analysis, Data and Analytics, Diagnostic Equipment, Science and Engineering, Software, Health Care, Machine Learning |
| Keywords | Precision Medicine, Ai Driven Diagnostics, Medical Data Science, Advanced Diagnostics, Machine Learning Healthcare, Next Generation Diagnostics, Biomarker Discovery, Artificial Intelligence Medicine, Clinical Decision Support, Healthcare Analytics, Data Driven Healthcare, Digital Health, Health Informatics, Big Data Analytics, Scientific Research, Drug Discovery, Therapeutic Target Identification |
| Competitors | Tempus Labs, Inc., GRAIL, Freenome, PathAI, Biofourmis, Proscia, Aiforia Technologies, Zebra Medical Vision Ltd, CureMetrix, SignalPath +36 more (view full list) |
Looking for a particular Aignostics employee's phone or email?
The Aignostics annual revenue was $21 million in 2026.
Viktor Matyas is the Co-founder and CEO of Aignostics.
98 people are employed at Aignostics.
Aignostics is based in Berlin, Berlin.